
Koninklijke Philips NV
PHIA#127 of 134 by buybacksAS · Healthcare · Medical Devices · Netherlands
philips.comBuybacks · FY2025€0≈ $0 · reported in EUR
Buyback yield0.0%repurchases ÷ market cap
Dividends · FY2025€328Mdividend yield 1.5%
Shareholder yield1.5%buybacks + dividends ÷ market cap
Shares outstanding · 5 yr+8.3%969M shares (2026)
Buybacks ÷ free cash flow0%payout incl. dividends 36%
Fiscal-year detail
From the cash-flow statement as reported, in EUR. Negative repurchases mean net share issuance.
| Fiscal year | Repurchases | Dividends | Free cash flow |
|---|---|---|---|
| FY2025Dec 2025 | €0 | €328M | €903M |
| FY2024Dec 2024 | €411M | €1.00M | €893M |
| FY2023Dec 2023 | €662M | €2.00M | €1.49B |
| FY2022Dec 2022 | €187M | €412M | −€979M |
| FY2021Dec 2021 | €1.64B | €482M | €866M |
| FY2020Dec 2020 | €343M | €1.00M | €1.83B |
| FY2019Dec 2019 | €1.38B | €453M | €1.02B |
Repurchases in FY2025 were −100.0% versus the prior year.
About Koninklijke Philips NV
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and s…
- Market cap
- €21.3B
- P/E (trailing)
- 18.9×
- Fiscal year end
- December
- ISIN
- NL0000009538
- Reporting currency
- EUR
- Data updated
- Oct 9, 2026